Optherion
New Haven · Founded 2005
About Optherion
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration, dense deposit disease, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. The company was founded in 2005 and is based in New Haven, Connecticut.
Company Facts
- Founded: 2005
- Legal name: Optherion, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $42.0M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Sep 2009)
- Website: optherion.com
- Phone: 2034920287
Social Profiles
Canonical: https://fsome.com/organization/optherion-8385165 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.